
    
      During open label treatment, all receive CBT and bupropion and nicotine patch. At week 10
      those who continue to smoke will be switched to varenicline through week 26. At week 10 those
      who are abstinent and report low levels of craving and low levels of depression symptoms will
      be withdrawn from study medications. Those who are abstinent but report difficulty with
      craving or depression symptoms will remain on zyban and nicotine replacement therapy (NRT)
      through week 26. Medication will not be available after week 26. All will receive CBT through
      week 26.
    
  